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Enterobacteriaceae co-producing NDM- and OXA-48-type carbapenemases
were encountered in higher frequency in the United Arab Emirates (UAE) than in the
neighboring countries in our earlier study. The aim of this investigation was to
characterize the seven double carbapenemase producer Klebsiella pneumoniae found
in the region to assess factors contributing to their emergence. Three K. pneumoniae
ST14 isolated in the UAE harboring blaNDM-1 on IncHI1b and blaOXA-232 on IncColE
plasmids were clonally related. Furthermore, two K. pneumoniae from the UAE,
ABC106 and ABC137 belonged to ST307 and ST1318, respectively. ABC106 carried
blaNDM-1 on IncHI1b, and blaOXA-162 on IncL/M plasmids, whereas ABC137
possessed blaNDM-1 on IncX3 and blaOXA-48 on IncL/M plasmids. The double
carbapenemase-producing K. pneumoniae from Oman (OMABC109) and Saudi
Arabia (SA54) belonged to ST11 and ST152, respectively. OMABC109 harbored
blaNDM-1 on an IncHI1b plasmid highly similar to the NDM-plasmid of ABC106 and
carried a chromosomally coded blaOXA-181 located on Tn2013. SA54 possessed a
blaNDM-1 on an IncFIb/FII plasmid and a blaOXA-48 on an IncL/M plasmid. Based on
these ﬁndings, clonal spread and horizontal transfer of carbapenemase genes located
on transposons or self-transmissible plasmids contributed equally to the emergence of
double carbapenemase-producing Enterobacteriaceae in the region.
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Introduction
The emergence and rapid spread of carbapenem-resistant Enterobacteria-
ceae (CRE) is a major global concern [1]. In the majority of cases carbepenem
resistance is due to the production of carbapenemases with varying levels of
hydrolyzing activity against other beta-lactams. Carbapenemase enzymes belong
either to Ambler class A, B, or D beta-lactamases. Their geographical distribution
varies, but in general the most common ones are the KPC-, IMP-, VIM-, NDM-,
and OXA-48-type enzymes. These enzymes often coded by genes located, as part
of composite transposons, on conjugative plasmids that further facilitate their
horizontal transfer [2].
It is likely that this mobile nature of carbapenemase genes has contributed to
the emergence of Enterobacteriaceae, mostly Klebsiella pneumoniae, producing
two or occasionally even three different carbapenemase genes. In Greece, where
such isolates were ﬁrst encountered, common combination of carbapenemases
includes strains co-producing KPC-2 and various alleles of VIM [3, 4]. In other
parts of the world, including the United States, Denmark, Turkey, Singapore, and
India, strains expressing NDM-type carbapenemases together with OXA-48-like
enzymes had emerged [5–9].
In a previous study investigating the molecular epidemiology of CRE in
the Arabian Peninsula, we encountered ﬁve Klebsiella pneumoniae isolates
co-producing NDM- and OXA-48-type carbapenemases in the United Arab
Emirates (UAE) representing 8.9% of CRE isolates of this country. This was a
considerable higher proportion than in other countries of the region [i.e., 1.9%,
0%, and 1.6% in the Kingdom of Saudi Arabia (KSA), Oman, and Kuwait,
respectively] [10]. The aim of this study was to subject these ﬁve Emirati
strains and the two isolates from the KSA and from Oman producing double
carbapenemase to detailed molecular analysis to reveal whether the higher rate
of such isolates in the UAE is due to a clonal expansion or, alternatively, to the
emergence of unrelated strains.
Methods
Bacterial strains
The strains were encountered between April 2009 and 2013 during a
previously published study [10]. The most important features of the isolates are
summarized in Table I.
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Antibiotic susceptibility assays
Susceptibility to cefotaxime, ceftazidime, aztreonam, ertapenem,
meropenem, imipenem, ciproﬂoxacin, gentamicin, amikacin, trimethoprime/
sulfamethoxazole, tetracycline, chloramphenicol, and colistin was tested
by broth microdilution, whereas tigecycline resistance was assessed by agar
dilution [11]. For interpretation, the CLSI clinical breakpoints were used [11],
with the exception of colistin and tigecycline interpreted by the EUCAST criteria
(www.eucast.org).
Molecular characterization of the strains
The multilocus sequence type (MLST) of the isolates and the macrorestriction
pattern of the XbaI-digested genomic DNA were established as described
earlier [12, 13].
Resistance genes (blaTEM, blaCTX-M, blaSHV, blaPER, blaAmpC, blaNDM,
blaOXA-48-like, blaKPC, blaVIM, blaIMP, armA, rmtA, rmtB, rmtC, rmtD, qnrS, qepA,
and aac6-1b-cr) were detected by PCR, as previously described [10, 12, 13].
The speciﬁc alleles of blaTEM, blaSHV, and blaCTX-M beta-lactamase genes were
determined by direct sequencing of the respective amplicons.
Characterizations of carbapenemase-bearing plasmids
Plasmids were routinely detected and sized by the alkaline lysis method of
Kado and Liu [14] using the episomes in E. coli V517 [15] and E. coli 39R861
[16] as molecular mass standards. A Na-azide-resistant derivative of E. coli J53
(J53RAZ) was used as recipient in conjugation. Competent cells of E. coli J53RAZ
or of E. coli DH5α were used in transformation experiments. blaNDM plasmids-
carrying derivatives were selected on plates containing 8 mg/L ceftazidime and
150 mg/L Na-azide, whereas those carrying blaOXA-48-like-bearing plasmids were
selected on plates supplemented with 0.5 mg/L ertapenem, 200 mg/L dipicolinic
acid, and 150 mg/L Na-azide. Transfer experiments were considered successful,
if a single plasmid containing derivative was obtained. This was conﬁrmed by
PCR targeting the respective carbapenemase gene and by Southern blotting and
hybridization of the plasmid electrophoresis gel. Attempts to detect extra-large
plasmids were carried out by S1 nuclease digestions as described [13]. PCR-based
replicon typing was done as described earlier [17, 18]. Southern blotting
and hybridization of plasmids separated by regular gel electrophoresis or after
S1 digestion was carried out as previously described [12].
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Plasmid restriction fragment length polymorphism (RFLP), applying
BamHI, SmaI, and XbaI restriction endonucleases, was used to compare plasmids
of the same molecular mass and incompatibility type, carrying the same
carbapenemase with identical ﬂanking regions in clonally unrelated strains [12].
Characterization of the genetic environment of blaNDM and blaOXA-48-like genes
The genetic scaffold of blaNDM and blaOXA was determined by PCRmapping,
using crude plasmid extracts as a DNA template from the clinical isolates as
described earlier [12]. This approach failed to map the blaNDM surrounding of
K. pneumoniae OMABC109 and ABC120, therefore, pOMABC109-NDM
and pABC120-NDM were digested with HindIII restriction endonuclease, and the
fragments were cloned into pUC19 and transformed into E. coliDH5α. The blaNDM-
bearing fragments cloned into pUC19 were selected on Triptic Soy Agar medium
containing 8 mg/L ceftazidime. The blaNDM-containing pUC19 plasmids were
puriﬁed with Plasmid Mini Kit (Qiagen NV, Venlo, The Netherlands), and used as
templates for sequencing the structures surrounding the blaNDM [19].
Sequencing
PCR amplicons were puriﬁed with Wizard® SV Gel and PCR Clean-Up
System (Pomega, USA). Plasmids were puriﬁed from single plasmid containing
transconjugants or transformants using Plasmid Maxi Kit (Qiagen). Sequencing
was performed with the Big Dye Cycle Terminator V.3.1 (Thermo Fisher
Scientiﬁc, Waltham, MA, USA) on the 3130X Genetic Analyzer (Applied
Biosystems) according to the manufacturer’s instructions. The sequences obtained
were analyzed using MEGA 4 and assembled with Clone Manager v9 software.
The assembled sequences were annotated using Sequin (http://www.ncbi.
nlm.nih.gov/Sequin) and submitted to GenBank.
Results
Antibiotic susceptibility
All clinical isolates tested were multidrug resistant, i.e., resistant to all
beta-lactam antibiotics tested with the exception of ABC127 and ABC128
remaining susceptible to aztreonam. The strains were also resistant to the majority
of non-beta-lactam antibiotics tested. Nonetheless, all seven strains remained
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susceptible to colistin, and none of them exhibited tigecycline resistance, although
tigecycline MIC of ABC127, ABC128, and ABC137 exceeded the clinical
breakpoint of 1 mg/L (Table II).
Molecular characteristics
The seven strains exhibited ﬁve distinct pulsed-ﬁeld gel electrophoresis
(PFGE) patterns, with one group clustering three of the strains also sharing the
ST14 sequence type (Figure 1, Table I). The remaining four isolates were not
related to this group and did not show similarity by PFGE or MLST (Table I). The
speciﬁc MLST types and the antibiotic-resistance genes detected in each isolate
are shown in Table I.
Localization of the carbapenemase genes
To reveal their possible plasmid localization, attempts were made to transfer
the blaNDM and blaOXA-48-like genes by conjugation into a Na-azide-resistant
derivative of E. coli J53 (J53RAZ). blaNDM-containing transconjugants were
obtained from all strains. However, in case of K. pneumoniae ABC137, the
transconjugants obtained always carried multiple plasmid bands. Therefore, from
one of these transconjugants, a crude plasmid extract was used to transform
competent cells of J53RAZ resulting in single, blaNDM-carrying plasmid containing
derivatives.
Attempts to conjugally transfer of blaOXA-48-like carrying plasmid failed with
all clinical isolates except for ABC106. However, we were successful to get single
plasmid containing transformants carrying the respective blaOXA-48-like genes in
E. coli DH5α using the crude plasmid extracts of ABC120, ABC127, ABC128,
ABC137, and SA54.
Plasmid incompatibility types of carbapenemase-bearing plasmids were
conﬁrmed by PCR-based replicon typing, as well as by hybridization of the
plasmid gels of the wild-type strains and single plasmid containing transconju-
gants or transformants. The size, incompatibility types, and genes co-transferring
with the plasmids are shown in Table III. It should be noted that the approximately
110 kb NDM plasmid of SA54 harbored double replicase genes of incompatibility
types FIb and FII. In this latter case, beyond PCR and hybridization, this
incompatibility type was also conﬁrmed by sequencing the respective region of
the puriﬁed plasmid.
Transfer of the blaOXA-48-like gene from OMABC109 was unsuccessful
either by conjugation or by transformation. Therefore, S1 nuclease digestion of
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OMABC109 was carried out and the gel was hybridized using an OXA-181 probe,
which localized the gene on the chromosome.
The genetic surrounding of the blaNDM and blaOXA-48-like genes
To compare the genetic support of the respective carbapenemase genes, the
sequence of the regions ﬂanking them was also determined.
The regions downstream of the blaNDM-1 genes were identical in all isolates
containing a bleomycin-resistance gene bleMBL. Immediate upstream of the
blaNDM-1 gene, all plasmids contained varying sizes of the 3′ end of the ISAba125.
Further upstream, the plasmids of the three clonally related isolates (ABC120,
ABC127, and ABC128, respectively) were also identical containing an ISEc33
element. It was noteworthy that in the plasmids of ABC106 and OMABC109,
while belonging to the same Inc type (HI1b) and exhibiting similar molecular mass
(>160 kb), the region upstream of the carbapenemase gene contained a longer
stretch of ISAba125 (254 bp instead of 101 bp) and an IS3000 element.
The respective regions of the NDM plasmids of ABC137 and SA54 were
completely different. In the former one, an IS5 element was identiﬁed, whereas
the latter one contained a ribosomal methylase gene, rmtC upstream of a
97-bp-long 3′ end of ISAba125 transposase (Figure 2). The sequences surrounding
of the blaNDM-1 in ABC106, ABC120, ABC137, OMABC109, and SA54 isolates
were deposited in the GenBank under accession numbers: MF774792, MF774793,
MF774794, MF774795, and MF774796, respectively.
Although the class-D carbapenemases could not be mobilized by conjuga-
tion from six of the seven clinical isolates, mapping their genetic surrounding
conﬁrmed their location on mobile genetic elements. In pABC137-OXA, the
blaOXA-48 was located in a classical Tn1999 transposon, in pSA54-OXA, the same
allele was located in a Tn1999 variant disrupted by IS1R both upstream and
downstream of the carbapenemase gene. blaOXA-162 was found in a Tn1999.2
variant in the conjugative pABC106-OXA. In the Omani isolate OMABC109, the
Figure 1. Comparison of pulsed-ﬁeld gel electrophoresis (PFGE) patterns of double carbapenemase-
producing K. pneumoniae
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chromosomally located blaOXA-181 was located in a Tn2013 with ISEcp1 upstream
of the carbapenemase gene (GenBank accession numbers: MF774788, MF774790,
MF774787, and MF774789, respectively). In the clonally related isolates ABC120,
ABC127, and ABC128, blaOXA-232 was located on 6,141-bp-long ColE-type non-
conjugative plasmid (MF774791) as part of a truncated Tn2013 transposon in which
only the 206-bp 3′ end of the ISEcp1 was present upstream of the blaOXA-232 gene
(Figure 3). The complete sequence of this plasmid was almost identical to the ﬁrst
sequenced pOXA-232 (JX423831).
Plasmid RFLP
As OMABC109 K. pneumoniae ST11 and ABC106 K. pneumoniae ST307,
i.e., clonally unrelated strains, carried the blaNDM-1 on IncHI1b-type plasmids of
similar size, and the genetic surrounding of blaNDM-1 was identical in both, we
analyzed the similarity of these plasmids by RFLP. Although the restriction
patterns of the two plasmids were not completely identical, they showed a
considerable level of similarity (Figure 4).
Figure 2. Genetic surrounding of blaNDM-1 genes. The gray area indicates 100% identical regions
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Discussion
The possible advantages provided by the seemingly redundant expression of
multiple carbapenemases by a strain are a matter of speculation. One may assume
that the varying substrate proﬁles and hydrolytic efﬁcacies of the different
carbapenemases (e.g., the considerably reduced activity of some class D enzymes
against cephalosporins) may explain the better survival chances of cells carrying
multiple carbapenemase genes. Alternatively, or even simultaneously, as
the different carbapenemase genes often reside on different genomic entities
(i.e., on different plasmids or some on the chromosome, while others on plasmids)
may secure that, particularly in the absence of selective pressure, a single genetic
event will not result in a carbapenem-susceptible phenotype.
Whatever the reason is, the rate of double carbapenemase producers,
particularly NDM and OXA carbapenemase co-producing K. pneumoniae, is
emerging: beyond sporadic isolates detected in the USA, Singapore, Denmark,
and India [5, 6, 8, 9], clusters of clonally spreading such K. pneumoniae have been
described in Saudi Arabia [20]. Furthermore, a cluster of NDM-5 and OXA-181
co-producing pan-drug-resistant K. pneumoniae ST147 was also reported from the
UAE [21], showing a further evolutionary step in the development of antibiotic
resistance in this species. The strains investigated in this study were isolated earlier
than the above pan-drug-resistant isolates [21], and showed no genetic relatedness
Figure 3. Genetic surrounding of blaOXA-48-type genes
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to those strains. According to the results presented here, the higher proportion of
NDM- and OXA-48-like enzyme co-producing clinical isolates in the UAE
observed by us earlier [10] could only be partially explained by clonal expansion
of K. pneumoniae ST14, since two of the ﬁve strains from the UAE had no genetic
relatedness to these isolates or to each other. However, it is interesting to note that
double carbapenemase-producing isolates of the UAE harbored NDM plasmids
similar to ones described earlier from the region. K. pneumoniae ABC137 carried
blaNDM-1 on an IncX3-type plasmid shown earlier to contribute to the spread of
this carbapenemase in the UAE [12]. The other four isolates carried blaNDM-1 on
IncHI1b-type plasmids, which was encountered earlier in the UAE and also in
Oman [12, 22]. Furthermore, the highly similar pABC106-NDM of ABC106
K. pneumoniae ST307 from the UAE and pOMABC109-NDM of OMABC109
K. pneumoniae ST11 from Oman showed similarities to pNDM-MAR
of a K. pneumoniae ST15 from Morocco, having identical incompatibility type
and regions ﬂanking blaNDM-1, and also carrying blaCTX-M-15 and qnrB1 genes
[23]. The same incompatibility-type plasmid, but with different insertion element
upstream of blaNDM-1, was present in the three clonally related K. pneumoniae
Figure 4. Plasmid restriction fragment length polymorphism of pABC106-NDM and pOMABC109-
NDM. Lane 1 and 10 Lambda concatemer (NEBiolabs), lanes 2 and 9 Lambda phage DNA digested
with HindIII restriction endonuclease, lane 3 pABC106-NDM digested with BamHI, lane 4
pOMABC109-NDM digested with BamHI, lane 5 pABC106-NDM digested with SmaI, lane 6
pOMABC109-NDM digested with SmaI, lane 7 pABC106-NDM digested with XbaI, and lane 8
pOMABC109-NDM digested with XbaI
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ST14. All these ﬁndings suggest the ability of this conjugative plasmid to establish
itself in global multidrug-resistant clones of K. pneumoniae.
Contrary to the NDM-plasmids, the majority of OXA-plasmids encountered
were not self-transmissible, although, with the exception of the blaOXA-232 genes,
all were located on mobile genetic elements known to be associated with the
spread of these enzymes [24]. Nevertheless, blaOXA-232 spread here due to the
clonal expansion of K. pneumoniae ST14. This observation is in line with previous
ﬁndings, as this particular carbapanemase was ﬁrst described in K. pneumoniae
ST14, and one of the ﬁrst double carbapenemase-producing isolates reported was
also a K. pneumoniae ST14 co-producing NDM-1 and OXA-232 [5, 25].
Characterization of these double carbapenemase-producing K. pneumoniae
encountered in the early phase of spread of CRE in the UAE illustrates the
complexity of the factors contributing to emergence of multidrug-resistant organisms.
Unlike in a classical outbreak situation largely due to clonal spread, double
carbapenemase-producing Enterobaceriaceae seem to have evolved due to
horizontal transfer of mobile genetic elements encountered earlier either in the
region or globally [10, 12, 24]. This latter way of transmission of antibiotic resistance
threatens the efﬁciency of infection prevention, originally designed to control
transfer of strains, i.e., their clonal spread and leaves antimicrobial stewardship
exercised across the whole spectrum of human and veterinary medicine the only
possible way to lessen the frequency of such horizontal gene transfer events.
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